20 funding opportunities found in this category. Change the order of results:
Lowest Award to Highest
Highest Award to Lowest
Request for Proposals: Funding Opportunities for Kennedy’s Disease Research
The Kennedy’s Disease Association (KDA) is planning to fund one or more research grants this fall to further the understanding of the pathological mechanisms of Kennedy’s Disease.
The KDA projects that funding for each grant will be up to $25,000.
Applications from junior investigators and from senior post-doctoral fellows are encouraged.
Your proposals must be received by Friday, June 21, 2013.
Cystinosis Foundation Deanna Lynn Potts Scholarship
Deanna Lynn Potts was born with Cystinosis and lived to be 27 years old. Before she died, she discussed her wishes to start a scholarship fund for children with Cystinosis.
We know how devastating a chronic illness can have on a family emotionally, physically, socially, and financially. Children with Cystinosis are living longer, thanks to medical science and therefore, embarking on careers.
These careers require education. Education is expensive, yet something we do not want to deprive our children of in our world today. Due to the financially draining medical costs, it might prove difficult to send a child to college.
Through this fund, we hope to help some of those students.
PURPOSE: To provide supplemental financial assistance to an undergraduate student diagnosed with Cystinosis enrolled in an accredited collegiate or vocational program.
SCHOLARSHIP AWARD: A $1000 scholarship awarded annually. The award is contingent upon the winners acceptance to an accredited college, university, or vocational program and will be payable to the education institution to be applied to tuition, room and board.
ELIGIBILITY: Each candidate must be a current high school senior, who has Cystinosis and have a financial need.
Documentation/verification of Cystinosis (e.g. letter from physician.)
An official copy of high school transcript.
Two letters of recommendation from current teachers/faculty members and/or counselors regarding applicant's scholastic aptitude and personal qualifications.
An essay of 500 words. We want to know a person who has played a vital role in student's life. How? Why? The essay should be typewritten and double spaced
A copy of the previous year's income tax return.
JUDGING CRITERIA: The essay will earn a possible 40 points and will be judged on the basis of rationale, grammar and comprehension. Transcripts and letters of recommendation will carry a possible additional 20 points. The Cystinosis Foundation Board will establish an independent judging panel to evaluate and rate the applicants. The decision of the judges is final. Finalists may be interviewed before selection is made.
DEADLINE FOR APPLICATION: Application and all accompanying documents must be received at the Cystinosis Foundation Office in a single, flat package by March 30th of each year. You can call the Cystinosis Foundation for an application 888-631-1588.
Remember, the deadline for receiving applications is March 30th of each year.
ALS Therapy Alliance Grants Program
Thank you for your interest in submitting a proposal for grant funding to the ALS Therapy Alliance (ATA). Our organization traditionally awards grants from one to three years in term ranging from $100,000 to $1 million in funding to both non- and for-profit companies. National and international companies are eligible to apply.
The following outline will help you prepare the information needed for our next funding review, which happens twice a year in April and November.
Please note grant submission deadlines and number of copies requested in order to ensure timely processing of your application. The ALS Therapy Alliance does not cover indirect costs.
If you have questions about the submission process or this application, please contact Ray Bisson, Grants Manager at (603) 664-5005 or email@example.com, or visit our FAQ page.
What to include with your grant proposal
ATA grant applications should follow the following format and adhere strictly to the maximum page limits (using only 11 point font or greater):
■ Abstract (1 page)
■ Background and Significance (2 pages)
■ Preliminary Data (2 pages)
■ Experimental Plan (3 pages)
■ References (no limit)
■ Budget Justification
■ NIH Biosketch (including present and pending support, 4 pages maximum) for PI's, post-docs and others involved in the project (excluding laboratory technicians)
■ Letters of collaboration and support
Grant proposal submission deadlines
To have your grant proposal reviewed at our April meeting, please submit by March 15th. To have your grant proposal reviewed at our November meeting, please submit by October 15th.
Where to send your grant proposal
Please email your proposal in PDF format to firstname.lastname@example.org.
Gilead Sciences Research Scholars Program in Cystic Fibrosis
Application Deadline: July 26, 2013
The mission of the Gilead Sciences Research Scholars Program in Cystic Fibrosis is to support innovative scientific research that will advance knowledge in the fields of pediatric and adult cystic fibrosis and provide support for early research career development. Gilead Sciences, Inc. hopes that the research supported by these awards will enhance understanding of cystic fibrosis.
The Program provides financial support to 3 junior faculty researchers for a 2-year period. Each award is funded up to $130,000, to be paid in annual installments of up to $65,000 per year for 2 years. Funding for the second year is contingent upon submission of a progress report and approval by the Scientific Review Committee Chair.
Recipients of these competitive awards will be selected by a Committee comprised of leaders in the field of cystic fibrosis (the "Scientific Review Committee" or the "Committee"). The Committee will review complete applications and select research proposals based on their scientific merit, feasibility, mentorship, environment, and candidate. Announcement of award recipients will be made at an awards dinner hosted by the Committee and senior representatives from Gilead.
Applicants must meet the eligibility criteria in order to be considered for an award.
This award is intended for junior faculty who are in the early stages of their career; specifically, the Applicant may be the recipient of a career development (K) award, or another mentored research award, but not an RO1 grant or equivalent.
Applicants must meet the following requirements:
Hold an MD, DO, PhD, or equivalent degree at time of award
Be within 7 years of a faculty appointment, or an assistant professor, in association with a research institution in the United States at the time of application
Have a strong career interest in cystic fibrosis
Have a research mentor with extensive experience in the field of cystic fibrosis
Be able to devote at least 50% of professional time to research (versus administrative, patient care, or teaching responsibilities)
Be able to complete the proposed research within the 2-year award period, providing evidence (manuscript, presentation, or abstracts) for future research projects
An Applicant must be a citizen or permanent resident of the United States or hold a temporary nonimmigrant visa. This visa must be valid for the two-year award period (January 2, 2014 – December 31, 2015).
For general inquires about the Research Scholars Program, please call or email:
Attn: Research Scholars Program Coordinator
If you are experiencing technical difficulties, please contact Zoomedia at 901-210-9564. If you have any other questions, please contact the Research Scholars Program Coordinator at 646-474-1820.
Children's Fund for Glycogen Storage Disease Research Grants Program
The Children's Fund for Glycogen Storage Disease Research accepts grant applications that relate to GSD1 research, diagnosis, and/or patient care. Grant application forms are available by request. Submissions should be via email only. You may contact our foundation by emailing us at email@example.com or by phoning (203) 272-CURE (2873).
June 30...Deadline for proposal submission
July 30...Board to meet regarding grants/fellowships awarded
August 15...Notification letters sent
August 30...Grant/fellowship monies disbursed
Request for Application: A-T Children's Project
Request for Application (RFA) for March 1, 2013 and September 1, 2013
Seed funding is now available for innovative proposals that seek to identify and validate biomarkers of A-T disease progression and that can be used to monitor therapeutic efficacy in clinical trials.
Please note that investigator-initiated proposals are also welcome for the March 1 and September 1 grant submission deadlines; however priority will be given to proposals that address the above referenced RFA.
We welcome investigators to contact Cynthia Rothblum-Oviatt, PhD, our Science Coordinator, if help is needed forming collaborations and/or obtaining reagents for A-T/ATM research.
Cynthia Rothblum-Oviatt, PhD
A-T Children's Project
5300 W. Hillsboro Blvd., Suite 105
Coconut Creek, FL 33073
Amyloidosis Foundation 2013 Senior Research Grant
History of the Amyloidosis Foundation: The Amyloidosis Foundation is a result of the merge of the Amyloidosis Research Foundation and the Amyloidosis Support Network in 2007. The ARF’s original mission was to support research for all types of amyloidosis and the ASN’s original mission was to increase awareness of the disease and support patients with information. The new organization maintains both missions with the intent of expanding our services to both patients and the medical and scientific community.
The grant program supports two research areas, basic scientific research and translational research. Applicants will have completed their doctoral studies or clinical fellowship more than ten (10) years prior to application to this program. Although a mentor is not a requirement, the involvement of one will be considered in the feasibility review of the proposal.
Complete applications must be received by August 1, 2013. You will receive a confirmation email or fax from the AF upon receipt of your application.
Selection and Considerations
The selection of the recipient(s) will be made by the Board of Directors of the foundation, after all applications have been reviewed by the Scientific Advisory Board, consisting of experts in the field of amyloidosis. Candidates are strictly prohibited from contacting any members of the advisory board regarding status of their application.
The committee will consider most favorably those proposals that provide evidence of an applicant’s research initiative and creativity. The committee will also consider the feasibility of meaningful results from the proposed research, and the likely contribution to the advancement of knowledge of Amyloidosis etiology, diagnosis, treatment, or prevention.
All candidates will receive notification from the AF office of the final selection of the recipient(s) via email or mail. The award announcement for this grant cycle will be no later than December 1, 2013.
Award Conditions and Reporting
The monetary award of $100,000US will be provided to the awardee's sponsoring institution in two payments of $50,000US for the direct support of the recipients work during the award year, which will begin January 1, 2014. Acknowledgement of receipt of the funds and date of receipt is required of the sponsoring institution.
At the mid point of the year, a brief update report must be submitted to the AF. This report is required prior to the release of the remaining funds. At the conclusion of the award year, the recipient is required to submit a brief written summary of the research conducted.
Recipients are expected to credit the foundation in any publications or presentations that result from the funded research.
Amyloidosis Foundation, Inc.
7151 N. Main St. Suite 2
Clarkston, MI 48346
Amyloidosis Foundation 2013 Junior Research Grant
The grant program supports two research areas, basic scientific research and translational research. Applicants will have completed their doctoral studies or clinical fellowship within ten (10) years prior to application to this program. Although a mentor is not a requirement, the involvement of one will be considered in the feasibility review of the proposal.
The monetary award of $50,000US will be provided to the awardees sponsoring institution in two payments of $25,000US for the direct support of the recipients work during the award year, which will begin January 1, 2014. Acknowledgement of receipt of the funds and date of receipt is required of the sponsoring institution.
Call for Proposals: NCL Research Award for Research on Batten Disease
The NCL Foundation provides regulary the NCL research award. The goal is to find a cure against the deadly children's disease Neuronal Ceroid Lipofuscinosis (NCL), also called Batten disease. This metabolic disorder is the most common neurodegenerative disease of childhood and is inevitably fatal. The gradual stages of the suffering are blindness, dementia, epilepsy, loss of speech, paralysis and complete helplessness.
We invite medical and basic science researchers worldwide to submit innovative clinical oriented or translational basic science projects, which can contribute to finding a cure for juvenile NCL.
Scientists from related areas of science including Alzheimer's disease, aging, and other lysosomal storage disorders, are particularly encouraged to apply with the aim to extend the NCL research community in move more efficiently towards a cure for NCL.
NCL Research Award 2013
This year, the NCL Foundation offers for the fifth time the NCL Research Award.
Grant monies (100,000 euros) are to be used for a postdoctoral fellowship in order to undertake the research project. In this fashion our goal is to promote the next generation of young NCL research scientists.
The deadline for applications: October 31, 2013
Please send the required documents to: Research@ncl-foundation.com